The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
Open accessAbstract
Validated biomarkers are needed to improve risk assessment and treatment decision-making for women with ductal carcinoma in situ (DCIS) of the breast. The Oncotype DX DCIS Score (DS) was shown to predict the risk of local recurrence (LR) in individuals with low-risk DCIS treated by breast-conserving surgery (BCS) alone. Our objective was to confirm these results in a larger population-based cohort of individuals. We used an established population-based cohort of individuals diagnosed with DCIS treated with BCS alone from 1994 to 2003 with validation of treatment and outcomes. Central pathology assessment excluded cases with invasive cancer, DCIS < 2 mm or positive margins. Cox model was used to determine the relationship between independent covariates, the DS (hazard ratio (HR)/50 Cp units (U)) and LR. Tumor blocks were collected for 828 patients. Final evaluable population includes 718 cases, of whom 571 had negative margins. Median follow-up was 9.6 years. 100 cases developed LR following BCS alone (DCIS, N = 44; invasive, N = 57). In the primary pre-specified analysis, the DS was associated with any LR (DCIS or invasive) in ER+ patients (HR 2.26; P < 0.001) and in all patients regardless of ER status (HR 2.15; P < 0.001). DCIS Score provided independent information on LR risk beyond clinical and pathologic variables including size, age, grade, necrosis, multifocality, and subtype (adjusted HR 1.68; P = 0.02). DCIS was associated with invasive LR (HR 1.78; P = 0.04) and DCIS LR (HR 2.43; P = 0.005). The DCIS Score independently predicts and quantifies individualized recurrence risk in a population of patients with pure DCIS treated by BCS alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Changes in breast cancer therapy because of pathology second opinions
Staradub, V. L., Messenger, K. A., Hao, N., Wiely, E. L., & Morrow, M. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02574516 · Cited by 91
Cited by
Morrow, M., Van Zee, K. J., Solin, L. J., Houssami, N., Chavez-MacGregor, M., Harris, J. R., Horton, J., Hwang, S., Johnson, P. L., Marinovich, M. L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.3573 · Cited by 386
Krstic, M., Kolendowski, B., Cecchini, M. J., Postenka, C. O., Hassan, H. M., Andrews, J., MacMillan, C. D., Williams, K. C., Leong, H. S., Brackstone, M., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5245 · Cited by 34
Self-citation
Metadata
- Authors
- Rakovitch, E., Nofech-Mozes, S., Hanna, W., Baehner, F. L., Saskin, R., Butler, S. M., Tuck, A., Sengupta, S., Elavathil, L., Jani, P. A., Bonin, M., Chang, M. C., Robertson, S. J., Slodkowska, E., Fong, C., Anderson, J. M., Jamshidian, F., Miller, D. P., Cherbavaz, D. B., Shak, S., & Paszat, L.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2015-06-29
- Volume
- 152
- Issue
- 2
- Pages
- 389-398
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W1531458427
- Cited by
- 230
- References
- 2
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. https://app.cochat.ai/papers/10.1007/s10549-015-3464-6
- The paper
- Rakovitch, E., Nofech-Mozes, S., Hanna, W., Baehner, F. L., Saskin, R., Butler, S. M., Tuck, A., Sengupta, S., Elavathil, L., Jani, P. A., Bonin, M., Chang, M. C., Robertson, S. J., Slodkowska, E., Fong, C., Anderson, J. M., Jamshidian, F., Miller, D. P., Cherbavaz, D. B., . . . Paszat, L. (2015). A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-015-3464-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.